Literature DB >> 1461944

Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.

M Waldo1, G Gerhardt, N Baker, C Drebing, L Adler, R Freedman.   

Abstract

Diminished neuronal response to repeated sensory input is a sensory-gating phenomenon that has been found to be deficient in schizophrenic patients. For example, schizophrenic patients fail to decrease the amplitude of the P50 wave of the auditory evoked potential to the second of paired click stimuli. In some studies, however, normal subjects have also failed to decrease their P50 responses. The aim of this study was to determine if accommodation to the recording situation over time would affect the gating of the P50 response. The gating of the P50 wave is measured as the ratio of the amplitude of the second response to the amplitude of the first. Three successive auditory evoked potentials were compiled, each from trains of 32 pairs of stimuli. Twelve normal subjects and 12 schizophrenic patients were studied. Unconjugated catecholamine metabolites were measured from venous samples drawn before and after the electrophysiological recording. Between the first and third trials, the normal subjects significantly increased their gating of P50. This increase in gating of P50 was related to decreased levels of the noradrenergic metabolite 3-methoxy-4-hydroxyphenylglycol. No similar phenomenon was observed in the schizophrenic patients, a number of whom had a further decrease in P50 gating over the three trials. Transient failure to observe gating of P50 in normal subjects may be related to increased state-dependent noradrenergic activity, which is known to disrupt sensory gating. This mechanism does not seem to account for the more persistent failure of sensory gating in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461944     DOI: 10.1016/0165-1781(92)90066-c

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Nicotine suppresses the P13 auditory evoked potential by acting on the pedunculopontine nucleus in the rat.

Authors:  N Mamiya; R Buchanan; T Wallace; R D Skinner; E Garcia-Rill
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

2.  Cortical evoked response to gaps in noise: within-channel and across-channel conditions.

Authors:  Jennifer J Lister; Nathan D Maxfield; Gabriel J Pitt
Journal:  Ear Hear       Date:  2007-12       Impact factor: 3.570

Review 3.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.

Authors:  David Potter; Ann Summerfelt; James Gold; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

4.  Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia.

Authors:  Ann Olincy; David L Braff; Lawrence E Adler; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Reuben C Gur; Gregory A Light; James Mintz; Keith H Nuechterlein; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Brandie D Wagner; Robert Freedman
Journal:  Schizophr Res       Date:  2010-04-10       Impact factor: 4.939

Review 5.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.

Authors:  Bruce I Turetsky; Monica E Calkins; Gregory A Light; Ann Olincy; Allen D Radant; Neal R Swerdlow
Journal:  Schizophr Bull       Date:  2006-11-29       Impact factor: 9.306

6.  Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.

Authors:  Sarah K Keedy; Megan Marlow-O'Connor; Beth Beenken; Jill Dorflinger; Marc Abel; Roland J Erwin
Journal:  Psychopharmacology (Berl)       Date:  2006-11-10       Impact factor: 4.530

7.  Profile of auditory information-processing deficits in schizophrenia.

Authors:  Bruce I Turetsky; Warren B Bilker; Steven J Siegel; Christian G Kohler; Raquel E Gur
Journal:  Psychiatry Res       Date:  2008-11-06       Impact factor: 3.222

8.  Olanzapine improves deficient sensory inhibition in DBA/2 mice.

Authors:  Johanna K Simosky; Robert Freedman; Karen E Stevens
Journal:  Brain Res       Date:  2008-07-25       Impact factor: 3.252

9.  Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity.

Authors:  Robert D Oades; Bernd Röpcke; Uwe Henning; Ansgard Klimke
Journal:  Behav Brain Funct       Date:  2005-08-09       Impact factor: 3.759

Review 10.  Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia.

Authors:  Premysl Vlcek; Petr Bob; Jiri Raboch
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-14       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.